HCV infection induces a unique hepatic innate immune response associated with robust production of type III interferons
about
Interferon (IFN) and Cellular Immune Response Evoked in RNA-Pattern Sensing During Infection with Hepatitis C Virus (HCV)Interferon Response in Hepatitis C Virus (HCV) Infection: Lessons from Cell Culture Systems of HCV InfectionVitamin D and chronic hepatitis C: effects on success rate and prevention of side effects associated with pegylated interferon-α and ribavirinModeling Viral Infectious Diseases and Development of Antiviral Therapies Using Human Induced Pluripotent Stem Cell-Derived SystemsInterferon-λ: Immune Functions at Barrier Surfaces and BeyondRegulation of hepatic innate immunity by hepatitis C virusImmune responses to HCV and other hepatitis virusesEmerging concepts in immunity to hepatitis C virus infection.ADAP2 Is an Interferon Stimulated Gene That Restricts RNA Virus EntryLeukocyte-derived IFN-α/β and epithelial IFN-λ constitute a compartmentalized mucosal defense system that restricts enteric virus infectionsTargeted induction of interferon-λ in humanized chimeric mouse liver abrogates hepatotropic virus infectionElevation of Alanine Aminotransferase Activity Occurs after Activation of the Cell-Death Signaling Initiated by Pattern-Recognition Receptors but before Activation of Cytolytic Effectors in NK or CD8+ T Cells in the Liver During Acute HCV InfectionHepatitis E virus persists in the presence of a type III interferon response.Transcriptional regulation of IFN-λ genes in hepatitis C virus-infected hepatocytes via IRF-3·IRF-7·NF-κB complexEx vivo induction of IFN-λ3 by a TLR7 agonist determines response to Peg-IFN/ribavirin therapy in chronic hepatitis C patients.Zinc is a potent and specific inhibitor of IFN-λ3 signalling.Protective immunity against hepatitis C: many shades of gray.IFN-λ4 potently blocks IFN-α signalling by ISG15 and USP18 in hepatitis C virus infection.Interferon lambda alleles predict innate antiviral immune responses and hepatitis C virus permissivenessEndogenous intrahepatic IFNs and association with IFN-free HCV treatment outcome.Hepatitis C virus in the new era: perspectives in epidemiology, prevention, diagnostics and predictors of response to therapy.An interferon response gene signature is associated with the therapeutic response of hepatitis C patientsThe association of toll-like receptor 4 polymorphism with hepatitis C virus infection in Saudi Arabian patients.Immune control and failure in HCV infection--tipping the balance.HepG2 cells mount an effective antiviral interferon-lambda based innate immune response to hepatitis C virus infection.Differential responses of plasmacytoid dendritic cells to influenza virus and distinct viral pathogens.Interferon lambda: opportunities, risks, and uncertainties in the fight against HCV.Functional characterization of canine interferon-lambdaIL28B polymorphism cannot predict response to interferon alpha treatment in patients with melanoma.Hepatitis C virus pathogen associated molecular pattern (PAMP) triggers production of lambda-interferons by human plasmacytoid dendritic cellsControl of the inflammatory response mechanisms mediated by natural and induced regulatory T-cells in HCV-, HTLV-1-, and EBV-associated cancers.Dendritic cells in hepatitis C virus infection: key players in the IFNL3-genotype response.Albumin fusion of interleukin-28B: production and characterization of its biological activities and protein stability.Permissivity of primary human hepatocytes and different hepatoma cell lines to cell culture adapted hepatitis C virus.A single nucleotide polymorphism associated with hepatitis C virus infections located in the distal region of the IL28B promoter influences NF-κB-mediated gene transcriptionAtaxia telangiectasia mutated kinase mediates NF-κB serine 276 phosphorylation and interferon expression via the IRF7-RIG-I amplification loop in paramyxovirus infection.Influence of genes suppressing interferon effects in peripheral blood mononuclear cells during triple antiviral therapy for chronic hepatitis C.Engrafted human stem cell-derived hepatocytes establish an infectious HCV murine modelControl of hepatitis C virus replication in mouse liver-derived cells by MAVS-dependent production of type I and type III interferons.Activins and Follistatin in Chronic Hepatitis C and Its Treatment with Pegylated-Interferon-α Based Therapy.
P2860
Q26778005-42CCC16A-9BA4-4182-BBCA-1AC8D8B399B2Q26784252-3384BBF6-28C7-4152-8532-64F7B631AE87Q26784321-1339C092-1B78-4DDE-91AB-553AEF1CC35FQ26799933-D23917A2-3C10-4F7B-8F25-0576ED1C81C4Q26801049-D7EF2055-1721-43F1-9AB6-4FB0612157C8Q26824743-BC6565DF-1961-4077-ACA3-217B2B8610EEQ26866955-2501E6AF-91EA-4FFD-91A6-30A859FEA4C2Q27002588-C6174F83-1DEB-4D8D-9151-BD2093E2BADEQ27317296-60046EFE-FD53-4878-895C-48BF52338FA8Q27320523-A56D0E10-2663-4AE9-8C06-533D8FE8A7F0Q27333253-D4382037-2FBE-4B7D-90C9-1EBA65A14894Q28553005-2602F467-8AAF-4ED4-ACDC-EE13DC355373Q30100969-FBD169C8-6DF9-4A09-8AF1-1A252915F9E3Q30407935-1919FC61-1C34-4BFC-B822-2DE04EE97428Q30444198-B978BDF1-630E-47D8-A4CC-81E0F45987E4Q33720876-87F4B2DA-2542-4A32-B23F-837DF680E895Q33759224-966DFD13-76E2-4BEC-98BE-A284D51DE7F9Q33812521-B4E63081-49B6-4575-84D5-F772A1B7A425Q33922537-944D8B5B-DFF2-46B9-A538-52C7B853A767Q33944295-EA7DD6B7-8643-4D4B-8EF7-4FCBC25AB2A4Q34008754-91A80B97-ACC1-45AB-94DB-869C93BA2A3EQ34027569-A02575D4-B6D5-4C7A-AD33-73E8A2B847D4Q34081261-E4517072-D482-4B95-988D-9389FCC42104Q34178628-F417D30F-E6F8-4EF3-BC39-13CB7123D88CQ34250323-8D665F29-6482-4F45-93D1-C63220203788Q34262112-7DE07279-9F66-46B3-9AE7-970B2EBAB9D5Q34433087-4486FE80-5154-4C63-AAFA-2F276CB9748DQ34439979-E682C1F8-A0BB-4F96-BE7B-01F28203E729Q34497983-07AF90CE-CE4F-4809-8D9B-212D8FE7CACEQ34699732-2B82DF67-65E5-45F3-8D59-0628FFFA8A98Q34708248-F747D629-B191-4409-8D5A-82923232717CQ34750577-1DF7227F-9879-4293-BCAD-45B59E2059DFQ34760439-E6084CF6-B76C-4862-813E-02F5E925CB1DQ34936072-EC0FFC8D-7012-4A6D-AA2E-C603C78095F4Q35014462-8489E3B3-3587-4EFD-B340-CD6899CEF8A8Q35076663-270F2799-6804-4E56-8014-231FEA614DC7Q35112598-13C02890-2060-40E4-8B35-60ED81F0EC28Q35140067-CC252841-A100-46B6-B1BA-8E2629AA3765Q35488054-25ED76BE-B69E-4CF5-98B0-E242F6207C11Q35563500-CBD0EFB1-8B99-4E19-AED8-6414B012158B
P2860
HCV infection induces a unique hepatic innate immune response associated with robust production of type III interferons
description
2012 nî lūn-bûn
@nan
2012 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
HCV infection induces a unique ...... uction of type III interferons
@ast
HCV infection induces a unique ...... uction of type III interferons
@en
HCV infection induces a unique ...... uction of type III interferons
@nl
type
label
HCV infection induces a unique ...... uction of type III interferons
@ast
HCV infection induces a unique ...... uction of type III interferons
@en
HCV infection induces a unique ...... uction of type III interferons
@nl
prefLabel
HCV infection induces a unique ...... uction of type III interferons
@ast
HCV infection induces a unique ...... uction of type III interferons
@en
HCV infection induces a unique ...... uction of type III interferons
@nl
P2093
P2860
P1433
P1476
HCV infection induces a unique ...... uction of type III interferons
@en
P2093
Ankit A Modi
Emmanuel Thomas
Mazen Noureddin
T Jake Liang
Veronica D Gonzalez
Weiping Chen
P2860
P304
P356
10.1053/J.GASTRO.2011.12.055
P407
P577
2012-01-13T00:00:00Z